Cargando…

Pharmacological and Epigenetic Regulators of NLRP3 Inflammasome Activation in Alzheimer’s Disease

Activation of the NLRP3 inflammasome complex results in the production of IL-18, Caspase-1 and IL-1β. These cytokines have a beneficial role in promoting inflammation, but an excessive activation of the inflammasome and the consequent constitutive inflammatory status is a negative factor in human pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	La Rosa, Francesca, Mancuso, Roberta, Agostini, Simone, Piancone, Federica, Marventano, Ivana, Saresella, Marina, Hernis, Ambra, Fenoglio, Chiara, Galimberti, Daniela, Scarpini, Elio, Clerici, Mario
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8623160/ https://www.ncbi.nlm.nih.gov/pubmed/34832969 http://dx.doi.org/10.3390/ph14111187

Ejemplares similares

TREM2 Expression and Amyloid-Beta Phagocytosis in Alzheimer’s Disease
por: La Rosa, Francesca, et al.
Publicado: (2023)

The NLRP3 and NLRP1 inflammasomes are activated in Alzheimer’s disease
por: Saresella, Marina, et al.
Publicado: (2016)

IL-33 and its decoy sST2 in patients with Alzheimer’s disease and mild cognitive impairment
por: Saresella, Marina, et al.
Publicado: (2020)

The Role of the Inflammasome in Neurodegenerative Diseases
por: Piancone, Federica, et al.
Publicado: (2021)

Alterations of the miR-126-3p/POU2AF1/Spi-B Axis and JCPyV Reactivation in Multiple Sclerosis Patients Receiving Natalizumab
por: Mancuso, Roberta, et al.
Publicado: (2022)

Modulation of MAPK- and PI3/AKT-Dependent Autophagy Signaling by Stavudine (D4T) in PBMC of Alzheimer’s Disease Patients
por: La Rosa, Francesca, et al.
Publicado: (2022)

Modulation of Neuroendocrine and Immunological Biomarkers Following Rehabilitation in Sarcopenic Patients
por: Piancone, Federica, et al.
Publicado: (2022)

Innate immune responses to three doses of the BNT162b2 mRNA SARS-CoV-2 vaccine
por: Saresella, Marina, et al.
Publicado: (2022)

JC virus detection and JC virus-specific immunity in natalizumab-treated Multiple Sclerosis patients
por: Mancuso, Roberta, et al.
Publicado: (2012)

Herpes simplex virus-1 (HSV-1) infection induces a potent but ineffective IFN-λ production in immune cells of AD and PD patients
por: La Rosa, Francesca, et al.
Publicado: (2019)

Glibenclamide-Loaded Nanoparticles Reduce NLRP3 Inflammasome Activation and Modulate miR-223-3p/miR-7-1-5p Expression in THP-1 Cells
por: Mancuso, Roberta, et al.
Publicado: (2023)

Monosodium Urate Crystals Activate the Inflammasome in Primary Progressive Multiple Sclerosis
por: Piancone, Federica, et al.
Publicado: (2018)

Alterations of natural killer cells activatory molecules phenotype and function in mothers of ASD children: a pilot study
por: Saresella, Marina, et al.
Publicado: (2023)

Role of Genetics and Epigenetics in the Pathogenesis of Alzheimer’s Disease and Frontotemporal Dementia(1)
por: Fenoglio, Chiara, et al.
Publicado: (2018)

Circulatory miR-223-3p Discriminates Between Parkinson’s and Alzheimer’s Patients
por: Mancuso, Roberta, et al.
Publicado: (2019)

Neuroinflammation and Brain Functional Disconnection in Alzheimer’s Disease
por: Baglio, Francesca, et al.
Publicado: (2013)

Immune and Imaging Correlates of Mild Cognitive Impairment Conversion to Alzheimer’s Disease
por: La Rosa, Francesca, et al.
Publicado: (2017)

Inflammatory Responses to Monomeric and Aggregated α-Synuclein in Peripheral Blood of Parkinson Disease Patients
por: Piancone, Federica, et al.
Publicado: (2021)

B Lymphocytes in Multiple Sclerosis: Bregs and BTLA/CD272 Expressing-CD19+ Lymphocytes Modulate Disease Severity
por: Piancone, Federica, et al.
Publicado: (2016)

MicroRNA-572 expression in multiple sclerosis patients with different patterns of clinical progression
por: Mancuso, Roberta, et al.
Publicado: (2015)

Increased Levels of Beta-Endorphin and Noradrenaline after a Brief High-Impact Multidimensional Rehabilitation Program in Multiple Sclerosis
por: d’Arma, Alessia, et al.
Publicado: (2022)

Indoleamine 2,3 Dioxygenase (IDO) Expression and Activity in Relapsing- Remitting Multiple Sclerosis
por: Mancuso, Roberta, et al.
Publicado: (2015)

Immunological and Clinical Effect of Diet Modulation of the Gut Microbiome in Multiple Sclerosis Patients: A Pilot Study
por: Saresella, Marina, et al.
Publicado: (2017)

Relationship between herpes simplex virus-1-specific antibody titers and cortical brain damage in Alzheimer’s disease and amnestic mild cognitive impairment
por: Mancuso, Roberta, et al.
Publicado: (2014)

Role of Oxidative Damage in Alzheimer’s Disease and Neurodegeneration: From Pathogenic Mechanisms to Biomarker Discovery
por: Buccellato, Francesca Romana, et al.
Publicado: (2021)

An Emerging Role for Long Non-Coding RNA Dysregulation in Neurological Disorders
por: Fenoglio, Chiara, et al.
Publicado: (2013)

MicroRNAs as Active Players in the Pathogenesis of Multiple Sclerosis
por: Fenoglio, Chiara, et al.
Publicado: (2012)

Deregulation of IL-37 and its miRNAs modulators in sarcopenic patients after rehabilitation
por: La Rosa, Francesca, et al.
Publicado: (2021)

Disease-modifying drugs in Alzheimer’s disease
por: Ghezzi, Laura, et al.
Publicado: (2013)

miR-23a-3p and miR-181a-5p modulate SNAP-25 expression
por: Agostini, Simone, et al.
Publicado: (2023)

Pharmacological Inhibitors of the NLRP3 Inflammasome
por: Zahid, Ayesha, et al.
Publicado: (2019)

Determinants of Disability in Multiple Sclerosis: An Immunological and MRI Study
por: Tortorella, Paola, et al.
Publicado: (2014)

NK Cell Subpopulations and Receptor Expression in Recovering SARS-CoV-2 Infection
por: Saresella, Marina, et al.
Publicado: (2021)

A role for activatory KIR/HLA complexes in HIV-associated Kaposi’s sarcoma development
por: Agostini, Simone, et al.
Publicado: (2011)

Influence of a High-Impact Multidimensional Rehabilitation Program on the Gut Microbiota of Patients with Multiple Sclerosis
por: Barone, Monica, et al.
Publicado: (2021)

Weight Loss Predicts Progression of Mild Cognitive Impairment to Alzheimer’s Disease
por: Cova, Ilaria, et al.
Publicado: (2016)

Activating KIR/HLA complexes in classic Kaposi's Sarcoma
por: Guerini, Franca R, et al.
Publicado: (2012)

CSF pro-orexin and amyloid-β38 expression in Alzheimer's disease and frontotemporal dementia
por: Heywood, Wendy E., et al.
Publicado: (2018)

The Role of the Innate Immune System in Alzheimer's Disease and Frontotemporal Lobar Degeneration: An Eye on Microglia
por: Ridolfi, Elisa, et al.
Publicado: (2013)

Epigenetic Regulation of Fatty Acid Amide Hydrolase in Alzheimer Disease
por: D'Addario, Claudio, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_5go48es0h9ve7omt3cibibkl6l